Professional Summary
Professional Overview
Brian McVeigh is a seasoned biopharmaceutical executive with over 25 years of experience in the industry. As the Chairman, Chief Executive Officer, and Co-Founder of Code BioTherapeutics, he is responsible for leading the company's strategic vision and overseeing the development of its innovative gene therapy platform. With a strong background in business development, mergers and acquisitions, and venture capital, Brian has played a pivotal role in shaping the growth and direction of several prominent life sciences organizations.
Experience Summary
Current Role
As the Chairman, Chief Executive Officer, and Co-Founder of Code BioTherapeutics, Brian is responsible for guiding the company's strategic direction, driving the development of its novel gene therapy technologies, and securing strategic partnerships and investments to accelerate the company's growth. Under his leadership, Code BioTherapeutics has positioned itself as a leading player in the gene therapy space, with a robust pipeline of promising drug candidates and a strong focus on addressing unmet medical needs.
Career Progression
Prior to his current role, Brian held several senior leadership positions at GlaxoSmithKline, where he was responsible for managing the company's worldwide business development transactions, commercial alliances, and mergers and acquisitions. As the Chief Executive Officer and Board Director of KBP BioSciences, he led the company's strategic initiatives and oversaw the successful development of its drug pipeline. Brian's extensive experience in the pharmaceutical and biotechnology sectors, coupled with his expertise in deal-making and venture capital, has made him a respected and influential figure in the industry.
Academic Background
Brian holds a Bachelor of Science degree in Finance from Pennsylvania State University, where he graduated with distinction.
Areas of Expertise
- Gene therapy and advanced therapy development
- Biopharmaceutical business development and deal-making
- Mergers, acquisitions, and strategic partnerships
- Venture capital and investment management
- Pharmaceutical operations and commercial strategy
Professional Impact
Throughout his career, Brian has been instrumental in driving the growth and success of multiple biopharmaceutical companies. His strategic vision, industry knowledge, and expertise in deal-making have enabled him to secure numerous partnerships, investments, and collaborations that have significantly advanced the development of novel therapies. As the Chairman and CEO of Code BioTherapeutics, Brian is poised to continue his legacy of innovation and impact, leading the company's efforts to transform the treatment of rare and genetic diseases.
Conclusion
With his extensive experience, proven track record of success, and deep industry expertise, Brian McVeigh is a respected and influential leader in the biopharmaceutical sector. As he continues to guide the development and commercialization of groundbreaking gene therapy technologies at Code BioTherapeutics, he remains committed to leveraging his expertise to drive meaningful advancements in the field and improve the lives of patients worldwide.
